In addition, Panmure Gordon has conditionally placed £3.4 million of existing shares on behalf of certain selling shareholders. e-Therapeutics is developing its own drug development pipeline, which includes
Fosmidomycin is a molecule that possesses antimalarial and antibacterial activity. The co-development project follows reports of the emergence of artemisinin resistance on the Thai-Cambodian border. Jomaa Pharma MD
Thestherapeutics include RNAi-, microRNA- and antisense-based drugs. Marina Biotech recently entered into a partnership with Debiopharm to fully fund the development of its bladder cancer program using its
ADI is a microbial enzyme, arginine deiminase that degrades the amino acid arginine. ADI-PEG 20 is ADI conjugated with polyethylene glycol (PEG), and can selectively kill cancer cells
The NurOwn technology processes adult human mesenchymal stem cells present in bone marrow which can self-renew and differentiate into many other cell types. The orphan status entitles BrainStorm
Oligonol is a proprietary form of lychee fruit extract which shows improved bioavailability due to its low-molecular weight polyphenols. The study measured the effects of Oligonol intake on
The randomised, placebo-controlled, multi-centre study was conducted by Glenmark Pharmaceuticals, the partner of Napo Pharmaceuticals. The study results showed that patients receiving crofelemer had significantly higher resolution of
The increase in net sales primarily resulted from increased demand of products in all product lines including glucose products, corn products and increased unit selling prices of glucose
San Diego-based ChemBridge is a global discovery chemistry company providing small molecule screening compound libraries, specialty building blocks for organic synthesis and custom chemistry services. Through this collaboration,
Reportedly, Pantarhei now has secured backing from international private equity investors. Reuters quoted Pantarhei Bioscience director (and former Organon executive) Herjan Coeling Bennink as telling the Dutch Financieele
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.